Mahaboobkhan Rasool

13PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityNutrigenomics and personalised nutritionLiquid biopsiesTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 19, 2025
Psoriasis Relapse: Exploring the Role of Epigenetics, Metabolic Reprogramming, and Inflammatory Memory.

Sakshi Wadhavane, Arulkumaran Rithvik, Mahaboobkhan Rasool

|Apr 11, 2024
3,3'-Diindolylmethane inhibits Th17 cell differentiation via impairing IRF-7-mediated plasmacytoid dendritic cell activation in imiquimod-induced psoriasis mice.

Mahaboobkhan Rasool, Manupati Srikanth, Arulkumaran Rithvik

|Dec 06, 2023
Resistin - A Plausible Therapeutic Target in the Pathogenesis of Psoriasis.

Manupati Srikanth, Mahaboobkhan Rasool

|Nov 30, 2023
Myricetin ameliorates the IL-21-induced tumorigenic phenotype of adjuvant-induced arthritis FLS by modulating the choline kinase signaling cascade.

Ann Miriam Jose, Mahaboobkhan Rasool

|Oct 27, 2021
CYT387 Inhibits the Hyperproliferative Potential of Fibroblast-like Synoviocytes via Modulation of IL-6/JAK1/STAT3 Signaling in Rheumatoid Arthritis.

Susmita Srivastava, Snigdha Samarpita, Ramamoorthi Ganesan

Pageof 3